JP2024508223A5 - - Google Patents
Info
- Publication number
- JP2024508223A5 JP2024508223A5 JP2023544092A JP2023544092A JP2024508223A5 JP 2024508223 A5 JP2024508223 A5 JP 2024508223A5 JP 2023544092 A JP2023544092 A JP 2023544092A JP 2023544092 A JP2023544092 A JP 2023544092A JP 2024508223 A5 JP2024508223 A5 JP 2024508223A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell
- cell population
- approximately
- population
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163142730P | 2021-01-28 | 2021-01-28 | |
| US63/142,730 | 2021-01-28 | ||
| US202263302225P | 2022-01-24 | 2022-01-24 | |
| US63/302,225 | 2022-01-24 | ||
| PCT/US2022/014247 WO2022165133A1 (en) | 2021-01-28 | 2022-01-28 | Methods for transducing immune cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024508223A JP2024508223A (ja) | 2024-02-26 |
| JP2024508223A5 true JP2024508223A5 (enExample) | 2025-02-04 |
Family
ID=80685286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023544092A Pending JP2024508223A (ja) | 2021-01-28 | 2022-01-28 | 免疫細胞を形質導入する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12365873B2 (enExample) |
| EP (1) | EP4284937A1 (enExample) |
| JP (1) | JP2024508223A (enExample) |
| KR (1) | KR20230135593A (enExample) |
| AU (1) | AU2022212090A1 (enExample) |
| CA (1) | CA3204357A1 (enExample) |
| IL (1) | IL303847B1 (enExample) |
| MX (1) | MX2023008662A (enExample) |
| TW (1) | TW202246517A (enExample) |
| WO (1) | WO2022165133A1 (enExample) |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5846534A (en) | 1988-02-12 | 1998-12-08 | British Technology Group Limited | Antibodies to the antigen campath-1 |
| US6319494B1 (en) | 1990-12-14 | 2001-11-20 | Cell Genesys, Inc. | Chimeric chains for receptor-associated signal transduction pathways |
| IL104570A0 (en) | 1992-03-18 | 1993-05-13 | Yeda Res & Dev | Chimeric genes and cells transformed therewith |
| US5827642A (en) | 1994-08-31 | 1998-10-27 | Fred Hutchinson Cancer Research Center | Rapid expansion method ("REM") for in vitro propagation of T lymphocytes |
| US6797514B2 (en) | 2000-02-24 | 2004-09-28 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
| HK1052372A1 (zh) | 2000-02-24 | 2003-09-11 | Xcyte Therapies, Inc. | 细胞的同步刺激和富集 |
| US6867041B2 (en) | 2000-02-24 | 2005-03-15 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
| AU2002368077B2 (en) | 2001-07-12 | 2010-03-04 | Jefferson Foote | Super humanized antibodies |
| US20120201794A1 (en) * | 2009-07-15 | 2012-08-09 | Calimmune Inc. | Dual vector for inhibition of human immunodeficiency virus |
| US9089520B2 (en) | 2010-05-21 | 2015-07-28 | Baylor College Of Medicine | Methods for inducing selective apoptosis |
| PH12013501201A1 (en) | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| WO2012129514A1 (en) | 2011-03-23 | 2012-09-27 | Fred Hutchinson Cancer Research Center | Method and compositions for cellular immunotherapy |
| CN103316356B (zh) | 2012-03-22 | 2016-08-17 | 北京三诺佳邑生物技术有限责任公司 | 一种重组慢病毒载体制剂 |
| GB201206559D0 (en) | 2012-04-13 | 2012-05-30 | Ucl Business Plc | Polypeptide |
| FR3010720B1 (fr) | 2013-09-16 | 2017-08-11 | Genethon | Procede de production de virus enveloppes |
| FR3014901B1 (fr) | 2013-12-17 | 2017-06-09 | Genethon | Procede de purification de virus ou vecteurs viraux enveloppes |
| KR20240164967A (ko) | 2014-02-04 | 2024-11-21 | 카이트 파마 인코포레이티드 | B 세포 악성종양 및 다른 암을 치료하는데 유용한 자가 t 세포 및 그의 조성물의 생산 방법 |
| EP3250602A1 (en) | 2015-01-26 | 2017-12-06 | Cellectis | T cell receptor knock out engineered immune cells, endowed with chimeric antigen receptors binding to cd123 for the treatment of relapsed/refractory acute myeloid lymphoma or blastic plasmacytoid dendritic cell neoplasm |
| IL292504B2 (en) * | 2015-10-20 | 2024-01-01 | Kite Pharma Inc | -methods of preparing t cells for t cell therapy |
| CN108884460B (zh) * | 2016-03-19 | 2023-04-28 | 埃克苏马生物技术公司 | 淋巴细胞转导及其扩增调节的方法与组合物 |
| WO2018161064A1 (en) * | 2017-03-03 | 2018-09-07 | F1 Oncology, Inc. | Methods and compositions for transducing and expanding lymphocytes and regulating the activity thereof |
| AU2017240801A1 (en) * | 2016-04-01 | 2018-10-25 | Amgen Inc. | Chimeric receptors to FLT3 and methods of use thereof |
| SG10202107808SA (en) | 2017-01-18 | 2021-08-30 | F1 Oncology Inc | Chimeric antigen receptors against axl or ror2 and methods of use thereof |
| EP3571294A1 (en) | 2017-01-18 | 2019-11-27 | F1 Oncology, Inc. | Methods of transducing and expanding immune cells and uses thereof |
-
2022
- 2022-01-28 US US17/587,138 patent/US12365873B2/en active Active
- 2022-01-28 EP EP22709435.6A patent/EP4284937A1/en active Pending
- 2022-01-28 TW TW111103878A patent/TW202246517A/zh unknown
- 2022-01-28 JP JP2023544092A patent/JP2024508223A/ja active Pending
- 2022-01-28 AU AU2022212090A patent/AU2022212090A1/en active Pending
- 2022-01-28 KR KR1020237025863A patent/KR20230135593A/ko active Pending
- 2022-01-28 CA CA3204357A patent/CA3204357A1/en active Pending
- 2022-01-28 MX MX2023008662A patent/MX2023008662A/es unknown
- 2022-01-28 WO PCT/US2022/014247 patent/WO2022165133A1/en not_active Ceased
- 2022-01-28 IL IL303847A patent/IL303847B1/en unknown
-
2025
- 2025-06-17 US US19/241,275 patent/US20260009000A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2703893B2 (ja) | 外来遺伝子物質を発現する上皮細胞 | |
| JP6691048B2 (ja) | 方法 | |
| AU2025204595A1 (en) | Platform for generating safe cell therapeutics | |
| US9670459B2 (en) | Production method for cell populations | |
| JPH11514879A (ja) | 原始ヒト幹細胞を有するＭｐ１リガンドの使用法 | |
| CN113660942A (zh) | 嵌合细胞因子受体 | |
| JP2026027332A (ja) | 栄養障害型表皮水疱症の治療薬 | |
| JP2019511238A (ja) | 遺伝子送達の増強方法 | |
| WO2008136670A2 (en) | Improved methods and means for lentiviral gene delivery | |
| JP2003517301A (ja) | 造血幹細胞のレンチウイルスベクター形質導入 | |
| JP7385230B2 (ja) | 移植用培養細胞または培養組織の調製方法 | |
| JP5911810B2 (ja) | 制御性ｔ細胞の製造方法 | |
| CN102046780A (zh) | 转染的细胞的生产方法 | |
| JP2006166918A5 (enExample) | ||
| CA2526670A1 (en) | Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith | |
| Bueren et al. | Genetic modification of hematopoietic stem cells: recent advances in the gene therapy of inherited diseases | |
| JP2006501829A (ja) | Ｈｏｘで誘導される増殖を制限する遺伝子をブロックする幹細胞増殖因子およびその方法 | |
| US20040029271A1 (en) | Pax5-deficient pro-B cells, methods of producing them and the use of such cells in human therapy | |
| EP1361268A1 (en) | Pax-5-deficient pro-B cells, methods of producing them and the use of such cells in human therapy | |
| JP2005514071A (ja) | 内皮細胞との前培養による遺伝子導入効率の上昇 | |
| WO2023140349A1 (ja) | 細胞シート | |
| WO2026015647A1 (en) | Compositions, systems, and methods for cell differentiation using targeted gene activation of dll4 and/or vcam1 | |
| CN121986158A (zh) | 从成人造血干细胞与祖细胞产生永生化巨核祖细胞以供体外量产功能性血小板的方法 | |
| Berson et al. | Selection of murine lymphoid and hematopoietic cells using polystyrene tissue culture devices containing covalently immobilized antibody | |
| Dory et al. | 426. Highly-Efficient Genome Modification in Human Mesenchymal Stem Cells Using Engineered Zinc Finger Nucleases |